IL Receptor
Interleukin receptors (IL receptors) are a group of receptors that bind to interleukins, a family of cytokines that play essential roles in immune system regulation, inflammation, and hematopoiesis. Dysregulation of interleukin signaling is associated with various inflammatory and autoimmune diseases, making IL receptors critical targets for therapeutic intervention. IL receptor antagonists are being explored for the treatment of conditions such as rheumatoid arthritis, psoriasis, and inflammatory bowel disease. At CymitQuimica, we offer a range of high-quality IL receptor modulators to support your research in cytokine signaling, immunology, and inflammatory disease therapy.
Found 116 products for "IL Receptor".
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Olokizumab
CAS:Revdofilimab (ABBV-368) is a human IgG monoclonal antibody targeting OX 40 with potential anticancer activity.Purity:99% (SDS-PAGE); 98.3% (SEC-HPLC) - 99% (SDS-PAGE); 98.3% (SEC-HPLC)Color and Shape:Transparent LiquidMolecular weight:145.39 kDaRisankizumab
CAS:Risankizumab (BI 655066) is a monoclonal antibody for psoriasis, targeting IL-23, with high affinity (Kd <10 pM) and an IC50 of 2 pM.Purity:SDS-PAGE:95.3%;SEC-HPLC:98.3%Color and Shape:Transparent LiquidMolecular weight:145.85 kDaSpesolimab
CAS:Spesolimab (BI 655130) is an antibody targeting IL-36 receptor, key in immunity, for systemic pustular psoriasis and dermatitis studies.Purity:> 95%Color and Shape:Transparent LiquidMolecular weight:150 kDaNidanilimab
CAS:Nidanilimab (CAN04) is an IL1RAP antibody with 1.10 pM affinity and antitumor effects on NSCLC and PDAC.Purity:> 95%Color and Shape:Transparent LiquidMolecular weight:150 kDaBriakinumab
CAS:Briakinumab (ABT-874) is a monoclonal antibody targeting IL-12, used in the research of psoriasis multiple sclerosis.Purity:>95%Color and Shape:Transparent LiquidMolecular weight:143.86 kDaAbrezekimab
CAS:Abrezekimab (VR 942), a humanized antibody, blocks IL-13/IL-13Rα1, for asthma/lung disease study.Purity:98.34% (SEC-HPLC) - 98.34% (SEC-HPLC)Color and Shape:LiquidMolecular weight:48.1 kDa2-Benzothiazolamine
CAS:2-ABT: nitrogen-rich heterocycle used in drug synthesis, inhibits P450, with anti-inflammatory, anticonvulsant, anticancer properties.Formula:C7H6N2SPurity:99.09% - 99.3%Color and Shape:SolidMolecular weight:150.2Nosantine racemate
CAS:Nosantine racemate is the racemate of Nosantine which is a IL-2 inducer or enhancer of IL-2 induction by phytohemagglutinin (PHA).Formula:C14H22N4O2Purity:98%Color and Shape:SolidMolecular weight:278.35Mepolizumab
CAS:Mepolizumab (SB 240563) is a humanized monoclonal antibody neutralizing IL-5.Purity:98% - 98%Color and Shape:Transparent LiquidMolecular weight:146.24 kDaCNTO4088
CNTO4088 serves as a functional therapeutic tool specifically designed to enable the precise detection and neutralization of the interleukin-23 protein which plays a pivotal role in maintaining the chronic inflammatory state during strictly monitored laboratory observation periods and molecular biology investigations to evaluate the pharmacological efficacy of targeted cytokine modulation in specialized preclinical research environments to facilitate the study of adaptive immunity.Color and Shape:Odour LiquidTorudokimab
Torudokimab (ZB-880) is a monoclonal antibody that neutralizes interleukin 33 and can be used to study immune system diseases.Purity:95.8% (SDS-PAGE); 96.2% (SEC-HPLC) - 95.8% (SDS-PAGE); 96.2% (SEC-HPLC)Color and Shape:Transparent LiquidMolecular weight:144.71 kDaStapokibart
CAS:Stapokibart (CM310) is a humanized monoclonal antibody targeting IL-4Rα, blocking IL-4Rα-mediated signaling. It is used in studies of atopic dermatitis.Purity:96.09% (SEC-HPLC) - 96.09% (SEC-HPLC)Color and Shape:LiquidMolecular weight:144.3 kDaAnti-inflammatory agent 42
CAS:Anti-inflammatory agent 42 has anti-inflammatory activity and inhibits the expression of TNF-α and IL-6 in LPS-stimulated macrophages.Formula:C20H12N2OSPurity:99.47%Color and Shape:Yellow SolidMolecular weight:328.39Pascolizumab
CAS:Pascolizumab (SB-240683) is a humanized monoclonal antibody against IL-4. Pascolizumab has asthmatic effects and can be used to study allergic rhinitis.Purity:> 95%Color and Shape:LiquidMolecular weight:147.18 kDaZiltivekimab
CAS:Ziltivekimab (MEDI 5117) is a CHO-expressed humanized monoclonal antibody targeting IL-6/IFNb2 for use in immune system diseases.Purity:97.2% (SDS-PAGE); 98.9% (SEC-HPLC) - 97.9% (SDS-PAGE); 97.3% (SEC-HPLC)Color and Shape:Transparent LiquidMolecular weight:145.39 kDaMyD88-IN-1
CAS:MyD88-IN-1: Potent MyD88 inhibitor with anti-inflammatory effects, blocking NF-κB and TLR/IL-1 pathways; potential for cancer and inflammation treatment.Formula:C23H24N6O7SPurity:99.99%Color and Shape:SoildMolecular weight:528.54Ref: TM-T77353
1mg50.00€5mg147.00€1mL*10mM (DMSO)161.00€10mg213.00€25mg354.00€50mg439.00€100mg625.00€500mg1,288.00€RYTVELA TFA
CAS:RYTVELA TFA is a variant interleukin-1 receptor inhibitor with anti-inflammatory activity for the prevention of preterm labor and fetal protection.Formula:C38H62N10O12Color and Shape:SolidMolecular weight:850.96Daclizumab
CAS:Daclizumab (Zenapax), a humanized antibody, blocks IL-2 by targeting CD25, used in multiple sclerosis.Purity:SDS-PAGE:95% SEC-HPLC:99.99%Color and Shape:Transparent LiquidMolecular weight:144.12 kDaDectrekumab
CAS:Dectrekumab (QAX576) is a humanized monoclonal antibody targeting IL-13.Purity:96.5% (SDS-PAGE); 97.1% (SEC-HPLC) - 96.5% (SDS-PAGE); 97.1% (SEC-HPLC)Color and Shape:LiquidMolecular weight:146.27 kDaCanakinumab
CAS:Canakinumab: Human IL-1β antibody, anti-inflammatory, treats gout & coronary disease, IC50 of 43.6 pM (human), 40.8 pM (monkey).Purity:98.8%Color and Shape:Transparent LiquidMolecular weight:145.18 kDa
